| RS181901181 |
RASGRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASGRP2-related disorder, RASGRP2-related disorder |
| RS181902304 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS181905023 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS1819058509 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1819058900 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1819059889 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181906086 |
CAPN14
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis |
| RS181911949 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 2, Achromatopsia 2 |
| RS1819149009 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS1819174200 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS181919231 |
DNAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS181923062 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS181923135 |
ATF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS181925915 |
CDC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Meier-Gorlin syndrome 5, CDC6-related disorder |
| RS181927766 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, CHARGE syndrome |
| RS181927900 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS181942192 |
SLC24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1D, Congenital stationary night blindness 1D |
| RS181942292 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS181943893 |
CTSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS181949335 |
TMPRSS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 8 |
| RS181951458 |
TACR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 11 with or without anosmia, Hypogonadotropic hypogonadism 11 with or without anosmia |
| RS1819520149 |
MAFA
|
Health Risk |
Pathogenic |
Islet cell adenomatosis, Islet cell adenomatosis |
| RS1819528679 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Pituitary stalk interruption syndrome, Pituitary stalk interruption syndrome |
| RS181952966 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS181955833 |
MCIDAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Ciliary dyskinesia |
| RS181957743 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS181958589 |
AGBL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Fuchs endothelial |
| RS181961360 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS181961566 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS181961770 |
FSCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1819628292 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Inborn genetic diseases |
| RS181963253 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS181967284 |
ARMC5
|
Health Risk |
Likely pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS181968345 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1819683853 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1819691962 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1819693631 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS181969865 |
TBCD
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS1819702000 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1819703656 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Melanoma-pancreatic cancer syndrome, Familial melanoma |
| RS181970528 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1819713922 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Lip and oral cavity carcinoma, Embryonal rhabdomyosarcoma |
| RS1819719137 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1819719250 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1819724486 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1819724531 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1819725713 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma-pancreatic cancer syndrome, Melanoma-pancreatic cancer syndrome |
| RS1819734528 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS181974243 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 45 |
| RS1819764921 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1819768982 |
KCNV2
|
Health Risk |
Likely pathogenic |
Cone dystrophy with supernormal rod response, Cone dystrophy with supernormal rod response |
| RS1819772981 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1819778559 |
KCNV2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1819778622 |
KCNV2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1819787095 |
KCNV2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1819797791 |
KCNV2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1819797955 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1819804753 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
CDKN2A-related disorder, Melanoma-pancreatic cancer syndrome |
| RS181980598 |
CSMD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1819808781 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS181983734 |
GSTT2
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1819856886 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS181988132 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS181989563 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS181989786 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS181990057 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS1819903817 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS181991723 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS1819924865 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS1819949737 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS181995380 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS1819961127 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1819962958 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1819968085 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS181998151 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS1819990660 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS182003715 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, Hereditary fructosuria |
| RS1820043726 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS182004440 |
TRPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182004703 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS182004761 |
ZNF674
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF674-related disorder, ZNF674-related disorder |
| RS1820048488 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1820085287 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS182009600 |
CNTNAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182015909 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS182018947 |
CEP152
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 9, primary |
| RS182019347 |
PIDD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS182021224 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS182024561 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS182027704 |
AFF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, AFF4-related disorder |
| RS182028200 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS182039780 |
GOSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS182045135 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Holoprosencephaly 7 |
| RS182048899 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS182049871 |
NME5
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS182050752 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block, type 1A |
| RS1820512673 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1820525500 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1820526139 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1820527497 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |